EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke

Victorien Monguillon iD, Peter J Kelly iD, Michelle L O'Donoghue iD, Jeong-Gun Park iD, Erin A Bohula iD, Jeffrey L Saver iD, Dan Atar iD, Anthony C Keech iD, Peter S Sever iD, Huei Wang, Gabriel Paiva da Silva Lima iD, Marc S Sabatine iD und 1 weitere

Circulation · 13.01.2026 · 153 (2) · 86-93

DOI: 10.1161/circulationaha.125.077549 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 13.01.2026. Verfasst von Victorien Monguillon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (V.M., M.L.O., J.-G.…. Hauptthemen laut MEDLINE: Cholesterol, LDL, Ischemic Stroke, Antibodies, Monoclonal, Humanized, Anticholesteremic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Amgen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with previous ischemic stroke are at high risk for recurrent stroke and other major adverse cardiovascular events. The benefits of achieving very low levels of low-density lipoprotein cholesterol (LDL-C) in such patients is unclear. METHODS: We analyzed patients with previous ischemic stroke enrolled in FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk), a randomized placebo-controlled trial studying evolocumab in patients with stable atherosclerotic cardiovascular disease (median follow-up, 2.2 years), and through the open-label extension (FOURIER-OLE) period (additional median follow-up, 5 years), to examine the relationship between achieved LDL-C and the long-term incidence of the primary end point (cardiovascular death, myocardial infarction, stroke, or hospitalization for unstable angina or coronary revascularization) and stroke-related end points. RESULTS: The analysis included 5291 patients with previous ischemic stroke (>4 weeks). Of these, 666 (12.6%), 1410 (26.6%), 586 (11.1%), 508 (9.6%), and 2121 (40.1%) patients achieved LDL-C values of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholesterol, LDLIschemic StrokeAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsHumansMaleFemaleAgedMiddle AgedTreatment OutcomeFollow-Up StudiesRisk FactorsProprotein Convertase 9

Stichwörter der Autor:innen

PCSK9 inhibitorscerebrovascular disorderscoronary artery diseaseischemic strokelipid regulating agentsstroke

Substanzen

Cholesterol, LDLAntibodies, Monoclonal, HumanizedevolocumabAnticholesteremic AgentsPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (V.M., M.L.O., J.-G.P., E.A.B., M.S.S., R.P.G.).
  • Mater Misericordiae University Hospital, Dublin, Ireland (P.J.K.).
  • School of Medicine, University College Dublin, Ireland (P.J.K.).
  • Health Research Board Stroke Clinical Trials Network Ireland, Dublin (P.J.K.).
  • Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, University of California-Los Angeles (J.L.S.).
  • Department of Cardiology, Oslo University Hospital Ulleval, Norway (D.A.).

ORCID-Profile: Victorien Monguillon, Peter J Kelly, Michelle L O'Donoghue, Jeong-Gun Park, Erin A Bohula, Jeffrey L Saver, Dan Atar, Anthony C Keech, Peter S Sever, Gabriel Paiva da Silva Lima, Marc S Sabatine, Robert P Giugliano

Förderung

  • Amgen

Zitieren

APA

Monguillon, V., Kelly, P. J., O'Donoghue, M. L., Park, J. G., Bohula, E. A., Saver, J. L., Atar, D., Keech, A. C., Sever, P. S., Wang, H., Paiva da Silva Lima, G., Sabatine, M. S., & Giugliano, R. P. (2026). Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke. Circulation, 153(2), 86-93. https://doi.org/10.1161/circulationaha.125.077549

Vancouver

Monguillon V, Kelly PJ, O'Donoghue ML, Park JG, Bohula EA, Saver JL, et al. Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke. Circulation. 2026;153(2):86-93. doi:10.1161/circulationaha.125.077549

BibTeX
@article{Monguillon2026,
  author = {Monguillon, Victorien and Kelly, Peter J and O'Donoghue, Michelle L and Park, Jeong-Gun and Bohula, Erin A and Saver, Jeffrey L and Atar, Dan and Keech, Anthony C and Sever, Peter S and Wang, Huei and Paiva da Silva Lima, Gabriel and Sabatine, Marc S and Giugliano, Robert P},
  title = {Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {2},
  pages = {86--93},
  doi = {10.1161/circulationaha.125.077549}
}
Kostenlos starten →